InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
T+90 hit rate
33%
T+90 mean return
-4.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Heerma Peter, Directeur Commercial. Officer active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 20 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €776k. Activity tracked since 13 August 2021. The latest transaction was filed on 14 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations20 total
14,000 shares0Common StockSEC:0001789617-26-000002:0
7,215 shares@ US$41.92880.0054% mcap39.7% of flowCommon StockSEC:0001789617-26-000002:1
5,591 shares@ US$35.00Common StockSEC:0001789617-25-000007:0
2,662 shares@ US$30.0011.3% of flowCommon StockSEC:0001789617-25-000006:0
891 shares0Common StockSEC:0001789617-25-000004:0
4,920 sharesCommon StockSEC:0001415889-25-012057:0
8,000 sharesCommon StockSEC:0001415889-25-003821:0
21,500 shares0Common StockSEC:0001415889-25-003063:0
1,584 shares@ US$18.94087.4% of flowCommon StockSEC:0001415889-25-002001:0
6,750 shares0Common StockSEC:0001415889-24-023092:0
25,000 shares0Common StockSEC:0001415889-24-002282:0
1,559 shares@ US$9.06843.3% of flowCommon StockSEC:0001415889-24-001797:0
3,091 shares@ US$8.25116.3% of flowCommon StockSEC:0001209191-23-051885:0
20,250 shares0Common StockSEC:0001209191-23-006425:0
1,550 shares@ US$21.90448.0% of flowCommon StockSEC:0001209191-23-005031:0
3,042 shares@ US$25.6820.1% of flowCommon StockSEC:0001209191-22-053018:0
9,840 shares0Common StockSEC:0001209191-22-006363:0
1,875 shares@ US$24.980.0010% mcap19.4% of flowCommon StockSEC:0001209191-22-005082:0
3,058 shares@ US$24.76980.0016% mcap30.6% of flowCommon StockSEC:0001209191-21-059353:0
4,500 shares0Common StockSEC:0001209191-21-052085:0
20 of 20 declarations
About Heerma Peter
Peter Heerma is the Chief Commercial Officer at Travere Therapeutics, Inc. He is responsible for commercial strategy and business development. With experience in the pharmaceutical sector, Peter plays a key role in developing strategies to increase sales and enhance market presence.
